Development of Sustainable Influenza Vaccine Production Capacity in Under Resourced Nations in Support of the Global Action Plan for Influenza Vaccines (GAP)

Post Date

June 4th 2013

Application Due Date

July 8th 2013

No Explanation

Funding Opportunity Number

EP-IDS-13-001

CFDA Number(s)

93.360

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

1

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Open to Non-U.S. entities

Funding

• Estimated Total Funding:

  $9000000

• Award Range:

  $9000000 - $9000000

Grant Description

The purpose of this funding opportunity announcement (FOA) is to support the objectives of the Global Action Plan for Influenza Vaccines (GAP) by also complementing the ongoing efforts by the ASPR/BARDA International Influenza Vaccine Manufacturing Capacity Building Program to build sustainable influenza vaccine production capacity in resource poor nations.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  HHS - Office of the Secretary

• Agency Contact:

  Grants.gov Contact Center
  Phone Number: 1-800-518-4726
  
  Hours of operation are 24 hours a day, 7 days a week. The contact center is closed on federal holidays.
  support@grants.gov
  

• Agency Mailing Address:

  Grants.gov Customer Support

• Agency Email Address:

  support@grants.gov

• Location:

  Assistant Secretary for Preparedness and Response

• More Information:

  Development of Sustainable Influenza Vaccine Production Capacity in Under Resourced Nations in Support of the Global Action Plan for Influenza Vaccines (GAP)